Resultados de procura - Matthew Flitter
- Mostrando 1 - 5 Resultados de 5
-
1
Kinetics of the Tau PET Tracer <sup>18</sup>F-AV-1451 (T807) in Subjects with Normal Cognitive Function, Mild Cognitive Impairment, and Alzheimer Disease por Sergey Shcherbinin, Adam J. Schwarz, Abhinay D. Joshi, Michael Navitsky, Matthew Flitter, William R. Shankle, Michael D. Devous, Mark A. Mintun
Publicado 2016Artigo -
2
Amyloid deposition detected with florbetapir F 18 (18F-AV-45) is related to lower episodic memory performance in clinically normal older individuals por Reisa A. Sperling, Keith A. Johnson, P. Murali Doraiswamy, Eric M. Reiman, Adam Fleisher, Marwan N. Sabbagh, Carl Sadowsky, Alan Carpenter, Mat D. Davis, Ming‐Chi Lu, Matthew Flitter, Abhinay D. Joshi, Christopher M. Clark, Michael Grundman, Mark A. Mintun, Daniel Skovronsky, Michael J. Pontecorvo
Publicado 2012Artigo -
3
Effectiveness of Florbetapir PET Imaging in Changing Patient Management por Michael J. Pontecorvo, Andrew Siderowf, Bruno Dubois, P. Murali Doraiswamy, Giovanni B. Frisoni, Michael Grundman, Flavio Nobili, Carl Sadowsky, Stephen Salloway, Anupa Arora, Antoine Chevrette, Walter Deberdt, Grazia Dell’Agnello, Matthew Flitter, Nick Galante, Mark Lowrey, Ming‐Chi Lu, Anne McGeehan, Michael D. Devous, Mark A. Mintun
Publicado 2017Artigo -
4
Positron Emission Tomography Imaging With [<sup>18</sup>F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes por Adam Fleisher, Michael J. Pontecorvo, Michael D. Devous, Ming‐Chi Lu, Anupa Arora, Stephen P. Truocchio, Patricia Aldea, Matthew Flitter, Tricia Locascio, Marybeth Devine, Andrew Siderowf, Thomas G. Beach, Thomas J. Montine, Geidy E. Serrano, Craig Curtis, Allison Perrin, Stephen Salloway, Misty Daniel, Charles Wellman, Abhinay D. Joshi, David J. Irwin, Val J. Lowe, William W. Seeley, Miloš D. Ikonomović, Joseph C. Masdeu, Ian Kennedy, Thomas S. Harris, Michael Navitsky, Sudeepti Southekal, Mark A. Mintun
Publicado 2020Artigo -
5
Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzhe... por Ming‐Chi Lu, Michael J. Pontecorvo, Michael D. Devous, Anupa Arora, Nicholas Galante, Anne McGeehan, Catherine Devadanam, Stephen Salloway, P. Murali Doraiswamy, Craig Curtis, Stephen P. Truocchio, Matthew Flitter, Tricia Locascio, Marybeth Devine, Jennifer A. Zimmer, Adam Fleisher, Mark A. Mintun, John Edmunds, Brian McCandless, Joseph Sam, E. Gordon DePuey, Alena Kreychman, Tammie L.S. Benzinger, Craig Curtis, John Olichney, Jose Delagandara, Murali Doraiswamy, Jaideep Sohi, Gigi Lefebvre, Pierre N. Tariot, Pradeep Garg, David Russell, Claudia H. Kawas, Geoffrey A. Kerchner, Ronald L. Korn, David Kudrow, Gil D. Rabinovici, Bharat Mocherla, Anil K. Nair, Brian R. Ott, Edward Zamrini, Carl Sadowsky, Stephen Salloway, Frederick W. Schaerf, William R. Shankle, Robert A. Stern, Bryan K. Woodruff, David A. Wolk, Keith A. Johnson, Tracy Butler, Amanda Smith, Bart Rydzewski
Publicado 2021Artigo
Ferramentas de procura:
Materias Relacionadas
Disease
Medicine
Nuclear medicine
Positron emission tomography
Alzheimer's disease
Dementia
Internal medicine
Pathology
Cognition
Cognitive impairment
Neuroscience
Psychology
Amyloid (mycology)
Audiology
Binding potential
Chemistry
Clinical Dementia Rating
Clinical endpoint
Clinical trial
Cognitive decline
Cognitive psychology
Kinetics
Nuclear physics
Physics
Pittsburgh compound B
Putamen
Quantum mechanics
Randomized controlled trial
Recall
Standardized uptake value